SEC 13F Intelligence

Highvista Strategies LLC / AGIO

Highvista Strategies LLC’s Agios Pharmaceuticals Inc Position

Does Highvista Strategies LLC own Agios Pharmaceuticals Inc (AGIO)? Not currently — the last reported position was 147.7K shares worth $4M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q4 2025
Shares
147.7K
% of Portfolio
+1.04%
Quarters Held
4
position exited

Position History AGIO

Reported value by quarter
Q1 ’25: $1MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $8MQ3 ’25Q4 ’25: $4MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025147.7K$4M+1.04%
Q3 2025195.3K$8M+1.92%
Q2 202570.1K$2M+0.86%
Q1 202544.1K$1M+0.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of AGIO.